This week on Health Wolters Kluwer Law & Business:
- Medicaid spending cut proposals; an analysis.
- The recession slows health care spending.
- The FDA reopens the comment period for “gluten free” labeling.
- The IOM recommends overhauling the medical device approval process.
- Compliance and privacy implications of “meaningful use.”
- A look at new standards in Medicare provider screenings.
